Avidity Biosciences LLC
News
Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
PR Newswire Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month Avidity Biosciences Joins Patient and Advocacy Communities in...\n more…
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings)
Benzinga Avidity Biosciences RNA has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.\n more…
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Aug...\n more…
Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
PR Newswire Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Avidity Biosciences Announces Closing...\n more…
This Early-Stage Biotech Stock Is Up 400% Should You Buy Now?
MarketBeat - AP News Avidity Biosciences' stock has performed incredibly well in 2024. Its Duchenne muscular dystrophy drug is showing strong results in trials...\n more…
Avidity Biosciences prices $300.1M upsized equity offering
Seeking Alpha - Healthcare Avidity Biosciences prices $300.1M upsized equity offering...\n more…